Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-12 Purchase | 2024-02-14 4:15 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 2,222,222 | $4.5 | $9,999,999 | 22,999,565 (Indirect) | View |
| 2023-11-15 Purchase | 2023-11-17 4:33 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 22,631 | $0.6852 | $15,507 | 21,743,413 (Indirect Direct) | View |
| 2023-03-10 Purchase | 2023-03-14 4:12 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 6,779 | $2.5956 | $17,596 | 20,777,343 (Indirect) | View |
| 2023-02-08 Purchase | 2023-02-10 4:32 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 1,500,000 | $2.6 | $3,900,000 | 20,770,564 (Indirect) | View |
| 2023-01-30 Purchase | 2023-02-01 4:31 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 184,272 | $4.9986 | $921,110 | 21,720,782 (Indirect Direct) | View |
| 2023-01-23 Purchase | 2023-01-25 4:38 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 9,900 | $4.9994 | $49,494 | 21,536,510 (Indirect Direct) | View |
| 2023-01-19 Purchase | 2023-01-23 4:25 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 69,739 | $2.4979 | $174,201 | 19,270,564 (Indirect) | View |
| 2023-01-19 Purchase | 2023-01-23 4:25 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 38,139 | $4.9976 | $190,603 | 21,526,610 (Indirect Direct) | View |
| 2023-01-17 Purchase | 2023-01-19 4:18 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 185,151 | $2.5105 | $464,827 | 19,200,825 (Indirect) | View |
| 2023-01-12 Purchase | 2023-01-17 4:36 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 5,378 | $4.9466 | $26,603 | 21,488,471 (Indirect Direct) | View |
| 2023-01-10 Purchase | 2023-01-12 4:40 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 309,070 | $4.7865 | $1,479,359 | 21,483,093 (Indirect Direct) | View |
| 2022-12-12 Purchase | 2022-12-14 4:31 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 300 | $4.9767 | $1,493 | 21,174,023 (Indirect Direct) | View |
| 2022-11-21 Purchase | 2022-11-23 4:21 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 40,327 | $4.9988 | $201,588 | 21,173,723 (Indirect Direct) | View |
| 2022-11-21 Purchase | 2022-11-23 4:12 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 9,615,384 | $2.6 | $24,999,998 | 19,015,674 (Indirect) | View |
| 2022-11-03 Purchase | 2022-11-07 4:30 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 139,148 | $4.9187 | $684,427 | 21,133,396 (Indirect Direct) | View |
| 2022-10-27 Purchase | 2022-10-31 5:20 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 76,877 | $4.8602 | $373,638 | 20,994,248 (Indirect Direct) | View |
| 2022-10-25 Purchase | 2022-10-27 6:58 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 123,820 | $4.8088 | $595,428 | 20,917,371 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-05 Other | 2024-04-08 8:05 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | TCG Opportunity III GP LLC 10% Owner | 1,000 | $0 | 2,000 (Indirect) | View |
| 2024-04-05 Disposition | 2024-04-08 8:05 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | TCG Opportunity III GP LLC 10% Owner | 20,344,505 | $0 | 2,000 (Indirect) | View |